The Price of Innovation

<p>Every time the U.S. tries to rein in rising drug prices, we hear the same thing from pharma: Stymie our profits, and you’ll get less innovation and fewer breakthrough treatments. Does the evidence back up this constant refrain?</p><br><p>Guests:</p><p><a href="https://profiles.stanford.edu/chaitan-khosla" rel="noopener noreferrer" target="_blank">Chaitan Khosla</a>, Director of Stanford ChEM-H</p><p><a href="https://www.kellogg.northwestern.edu/faculty/directory/garthwaite_craig.aspx" rel="noopener noreferrer" target="_blank">Craig Garthwaite</a>, Associate Professor of Strategy, Kellogg School of Management at Northwestern University</p><p><a href="https://www.vumc.org/health-policy/person/stacie-b-dusetzina-phd" rel="noopener noreferrer" target="_blank">Stacie Dusetzina</a>, Associate Professor of Health Policy, Vanderbilt University</p><br><p>Check out the research for yourself and learn more on our website:&nbsp;<a href="http://bit.ly/tradeoffsep8" rel="noopener noreferrer" target="_blank">http://bit.ly/tradeoffsep8</a> </p><p>&nbsp;</p><p>As they say in health care, there’s no such thing as a free podcast. Support our show:&nbsp;<a href="https://tradeoffs.org/donate" rel="noopener noreferrer" target="_blank">https://tradeoffs.org/donate</a></p><p>&nbsp;</p><p>Follow us on Twitter:&nbsp;<a href="https://twitter.com/tradeoffspod" rel="noopener noreferrer" target="_blank">https://twitter.com/tradeoffspod</a>&nbsp;</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>